Zagociguat (INN, USAN; developmental code names CY-6463 and IW-6463) is a brain-penetrant soluble guanylate cyclase (sGC) stimulator which is under development for the treatment of Alzheimer's disease, MELAS syndrome, mitochondrial disorders, dementia, and schizophrenia.
The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.